Allogeneic large multivalent immunogen melanoma vaccine LP2307
Term · Oncology and biomedicine · MLC-T-ONC-009916
A cancer vaccine, containing human-specific large multivalent immunogen (LMI) isolated from plasma membrane fractions of the melanoma cell lines MSM-M1 and MSM-M2, with potential immunostimulating and antineoplastic activities. Upon administration, allogeneic large multivalent immunogen melanoma vaccine LP2307 may stimulate a CD8+ cytotoxic T lymphocyte (CTL) response against melanoma tumor cells that express melanoma-specific LMI.
| Identifier | MLC-T-ONC-009916 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | allogeneic LMI melanoma vaccine LP2307 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009916",
"term": "Allogeneic large multivalent immunogen melanoma vaccine LP2307",
"field": "Oncology and biomedicine",
"definition": "A cancer vaccine, containing human-specific large multivalent immunogen (LMI) isolated from plasma membrane fractions of the melanoma cell lines MSM-M1 and MSM-M2, with potential immunostimulating and antineoplastic activities. Upon administration, allogeneic large multivalent immunogen melanoma vaccine LP2307 may stimulate a CD8+ cytotoxic T lymphocyte (CTL) response against melanoma tumor cells that express melanoma-specific LMI.",
"synonyms": [
"allogeneic LMI melanoma vaccine LP2307"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/allogeneic-large-multivalent-immunogen-melanoma-vaccine-lp2307/"
}
Record 802 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.